Do ADMA plasma levels correlate with disease severity and predict outcomes in patients with CTEPH?
ADMA plasma levels may serve as a useful biomarker for estimating the degree of small-vessel arteriopathy and predicting outcomes in patients with CTEPH.
ADMA plasma levels correlate with the severity of pulmonary vascular disease and predict outcome in patients with CTEPH. Measurement of ADMA plasma levels may be useful for estimating the degree of small-vessel arteriopathy in CTEPH.
Skoro‐Sajer et al. (Thu,) studied this question.